CERE
Swiss National Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-143,200
| Closed | -$5.86M | – | 2501 |
|
|
2024
Q2 | $5.86M | Hold |
143,200
| – | – | ﹤0.01% | 1174 |
|
|
2024
Q1 | $6.05M | Buy |
143,200
+3,500
| +3% | +$148K | ﹤0.01% | 1174 |
|
|
2023
Q4 | $5.92M | Buy |
139,700
+1,800
| +1% | +$76.3K | ﹤0.01% | 1182 |
|
|
2023
Q3 | $3.01M | Buy |
137,900
+1,500
| +1% | +$32.7K | ﹤0.01% | 1587 |
|
|
2023
Q2 | $4.34M | Buy |
136,400
+1,400
| +1% | +$44.5K | ﹤0.01% | 1395 |
|
|
2023
Q1 | $3.29M | Sell |
135,000
-15,500
| -10% | -$378K | ﹤0.01% | 1530 |
|
|
2022
Q4 | $4.75M | Buy |
150,500
+9,800
| +7% | +$309K | ﹤0.01% | 1342 |
|
|
2022
Q3 | $3.98M | Buy |
140,700
+1,900
| +1% | +$53.7K | ﹤0.01% | 1413 |
|
|
2022
Q2 | $3.67M | Buy |
138,800
+34,400
| +33% | +$910K | ﹤0.01% | 1502 |
|
|
2022
Q1 | $3.66M | Buy |
104,400
+8,800
| +9% | +$308K | ﹤0.01% | 1652 |
|
|
2021
Q4 | $3.1M | Buy |
95,600
+2,200
| +2% | +$71.3K | ﹤0.01% | 1771 |
|
|
2021
Q3 | $2.76M | Buy |
93,400
+23,300
| +33% | +$687K | ﹤0.01% | 1842 |
|
|
2021
Q2 | $1.8M | Buy |
+70,100
| New | +$1.8M | ﹤0.01% | 2186 |
|